Chemicals & Chemical Products / Peptides

This notice is a combined Synopsis / Solicitation Request for Quote for commercial items prepared in accordance with the format of FAR Subpart 12.6, in conjunction with FAR Part 13.5 as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested, and a written solicitation will not be issued for the solicitation NIAID-RFQ-12102, a request for quote. The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC2005-60 dated July 26, 2012. This acquisition will be processed under Simplified Acquisition Procedures (SAP) as a small business set-aside, however small disadvantage, minority, veteran owned, and HUB zone companies etc., are encouraged to submit proposals. The associated North American Industry Classification System (NAICS) Code is 325998, which has a size standard of 500 employees. The National Institute of Allergy and Infectious Diseases (NIAID) intends to procure the following peptides: 1) Ebola GP (Z) Carboxyl terminus acid peptides, 15.0mg, 15 amino acids in length, qty-102 each, and 2) Ebola GP (Z) Carboxyl terminus acid peptides, 15.0mg, 12 amino acids in length, qty-1 each. The vendor must be able to perform the following: 1) produce requested peptides (see attached spreadsheet for sequences), 2) Peptide yield should be at least 15.0 mg, 3) Peptide purity should be at least 80%, 4) HPLC and MS results should be provided for each peptide, and 5) Additional AA for N-terminal Q (Gln) should be included. The following factors will be used to evaluate offers: 1) capability to meet required specifications, 2) price, and 3) delivery (90 days after receipt of order). Place of delivery is Bethesda, Maryland 20892. The government will award a fixed price purchase order to the responsible contractor. The FOB point shall be Destination. The following Federal Acquisition Regulations provisions and clauses apply to the acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items; FAR 52.212-2 Evaluation Commercial Items; Far 52.212-3 Offeror Representation and Certifications Commercial Items; FAR 52.212-4 Contract Terms and Conditions Commercial Items; FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items; and FAR 52.232-33 Payment by Electronic Funds Transfer-Central Contractor Registration (Oct 2003). A completed copy of provisions at FAR 52.212-3 Offerors Representation and Certifications Commercial Items must be included which can be found online at System for Award Management (SAM) https://www.sam.gov. By submission of an offer, the Offeror acknowledges the requirement that a prospective Awardee shall be registered in the SAM database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation. [Note: Lack of registration in SAM will make an Offeror ineligible for award.] Copies of the aforementioned clauses are available upon request by telephone to Terry Knight at (301) 402-2282. All responsible sources may submit offers that will be considered by this agency. Offers must be submitted later than 5:00 p.m. Eastern Daylight Savings Time (EDST), September 17, 2012 by delivery through the U.S. Postal Service, to the address of NIH/NIAID/AMOB, 10401 Fernwood Road, Room 2NE52E, Bethesda, MD, 20892-4811. E-mail and fax submissions are prohibited.